Veterinarians & Vet Students

Information and resources for veterinary professionals and students of veterinary medicine

Enter

Pet Owners / Consumers

Learn about generic animal drugs & how they can protect your pet's health and the human food supply

Enter

GADA Members

Online resources and self-service features available exclusively for GADA Members Only

Enter

About GADA

Learn about the history, mission and objectives of the Alliance, and find out how to become a GADA Member

Enter

Latest News

FDA Warns About Risk of Xylazine Exposure in Humans
November 8, 2022
The FDA is communicating to health care professionals about serious risks associated with xylazine exposure in humans. FDA is aware that xylazine is increasingly detected in the illicit drug supply and in drug overdoses. Xylazine is an FDA-approved animal drug used as a sedative and analgesic in veterinary medicine, but is not approved for use in humans. The FDA has issued an Alert and a letter to stakeholders to communicate the risks and considerations for management.

FDA Announces Delay in GFI #256 Enforcement
September 22, 2022
On September 9, 2022, FDA announced a six-month delay in enforcement for its GFI #256, Compounding Animal Drugs from Bulk Drug Substances. Routine inspectional activities were to begin on October 1, 2022. The delay was requested by the Alliance for Pharmacy Compounding, American College of Veterinary Pharmacists, American Pharmacists Association, National Community Pharmacists Association, and Society of Veterinary Hospital Pharmacists, among others, who say pharmacies need additional time to review the recommendations or make suggested changes to processes, and to submit nominations for bulk drug substances for compounding office stock.

GADA Hails Introduction of Generic Animal Drug Advancement Act
September 15, 2022
The Generic Animal Drug Advancement Act, H.R. 8857, will update the Federal FD&C Act to correct current limitations to the approval of generic animal drug applications. The legislation would expand pathways for generic animal drugs to be approved as combination products, and update FDA animal drug labeling requirements to allow generic animal drugs to gain approval for a single species, rather than all species, labeled on a pioneer drug. MORE

Meetings & Events

Thursday, December 15, 2022
Special Member Meeting
2:00 pm Eastern

Thursday, February 23, 2023
GADA-CVM Triannual Meetings

Wednesday, June 21, 2023
GADA Mid-Year Member Meeting

Thursday, June 22, 2023
GADA-CVM Triannual Meetings

Wednesday, October 25, 2023
GADA Annual Member Meeting

Thursday, October 26, 2023
GADA-CVM Triannual Meetings